Browsed by
Tag: crowdfunding

Fundraiser by Lifespan.io & CellAge: Targeting Senescent Cells With Synthetic Biology

Fundraiser by Lifespan.io & CellAge: Targeting Senescent Cells With Synthetic Biology

Comments 0 Comment
The New Renaissance HatCellAge
******************************

Editor’s Note: The Rational Argumentator and the U.S. Transhumanist Party support Lifespan.io and CellAge in their work towards groundbreaking scientific life-extension research. Finding a way to repair age-related damage to senescent cells would be a fundamental breakthrough for transhumanism, and we offer our best wishes and support for those striving towards these new technologies.

               ~ Gennady Stolyarov II, Editor-in-Chief, The Rational Argumentator, December 11, 2016

From Lifespan.io and CellAge:

Our society has never aged more rapidly – one of the most visible symptoms of the changing demographics is the exponential increase in the incidence of age-related diseases, including cancer, cardiovascular diseases and osteoarthritis. Not only does aging have a negative effect on the quality of life among the elderly but it also causes a significant financial strain on both private and public sectors. As the proportion of older people is increasing so is health care spending. According to a WHO analysis, the annual number of new cancer cases is projected to rise to 17 million by 2020, and reach 27 million by 2030. Similar trends are clearly visible in other age-related diseases such as cardiovascular disease. Few effective treatments addressing these challenges are currently available and most of them focus on a single disease rather than adopting a more holistic approach to aging.

Recently a new approach which has the potential of significantly alleviating these problems has been validated by a number of in vivo and in vitro studies. It has been demonstrated that senescent cells (cells which have ceased to replicate due to stress or replicative capacity exhaustion) are linked to many age-related diseases. Furthermore, removing senescent cells from mice has been recently shown to drastically increase mouse healthspan (a period of life free of serious diseases).

Here at CellAge we are working hard to help translate these findings into humans!

CellAge, together with a leading synthetic biology partner, Synpromics, are poised to develop a technology allowing for the identification and removal of harmful senescent cells. Our breakthrough technology will benefit both the scientific community and the general public.

In short, CellAge is going to develop synthetic promoters which are specific to senescent cells, as promoters that are currently being used to track senescent cells are simply not good enough to be used in therapies. The most prominently used p16 gene promoter has a number of limitations, for example. First, it is involved in cell cycle regulation, which poses a danger in targeting cells which are not diving but not senescent either, such as quiescent stem cells. Second, organism-wide administration of gene therapy might at present be too dangerous. This means senescent cells only in specific organs might need to be targeted and p16 promoter does not provide this level of specificity. Third, the p16 promoter is not active in all senescent cells. Thus, after therapies utilizing this promoter, a proportion of senescent cells would still remain. Moreover, the p16 promoter is relatively large (2.1kb), making it difficult to incorporate in present gene therapy vehicles. Lastly, to achieve the intended therapeutic effect the strength of p16 promoter to drive therapeutic effect might not be high enough.

CellAge will be constructing a synthetic promoter which has a potential to overcome all of the mentioned limitations. A number of gene therapy companies, including uniQure, AGTC and Avalanche Biotech have successfully targeted other types of cells using this technology. With your help, we will be able to use same technology to develop tools and therapies for accurate senescent cell targeting.

Crowdfunding Longevity Science: An Interview with Keith Comito of Lifespan.io – Article by Reason

Crowdfunding Longevity Science: An Interview with Keith Comito of Lifespan.io – Article by Reason

Comments 0 Comment
The New Renaissance HatReason
******************************

Keith Comito leads the volunteers of the non-profit Life Extension Advocacy Foundation (LEAF) and the crowdfunding initiative Lifespan.io, a site I’m sure you’ve seen at least in passing by now. The LEAF crew have put in a lot of effort to help make fundraisers for rejuvenation research projects a success both last year and this year. Two such crowdfunding campaigns are running right now, firstly senolytic drug research at the Major Mouse Testing Program with just a few days left to go, and in its stretch goals, and secondly the recently launched drug discovery for ALT cancers at the SENS Research Foundation. Both tie in to the SENS portfolio of research programs aimed at effective treatment of aging and all age-related conditions. These are large projects when taken as a whole, but the way forward in this as in all things is to pick out smaller, achievable goals, and set out to get them done. Then repeat as necessary.

I recently had the chance to ask Keith Comito a few questions about Lifespan.io, the state of funding for the interesting end of longevity science, and what he envisages for the years ahead. This is an interesting, revolutionary time for the life sciences, in which progress in biotechnology has made early stage research very cheap. A great deal can be accomplished at the cutting edge of medical science given access to an established lab, administrators who can break out small initiatives from the larger goals, smart young researchers, and a few tens of thousands of dollars. It is an age in which we can all help to advance the research we care about, by collaborating and donating, and it has never been easier to just reach out and talk to the scientists involved. If you haven’t taken a look at Lifespan.io and donated to one of the projects there, then you really should. This is a way to move the needle on aging research, and advance that much closer to effective treatments for the causes of aging.

Quote:

What is the Lifespan.io story in brief? What was the spur that made you come together and decide to do your part in the fight against aging?

Lifespan.io began to take shape at the tail end of 2012, as a result of a loose discussion group based in New York which consisted of citizen scientists such as myself and Dr. Oliver Medvedik, supporters of SENS, as well as a few healthcare practitioners. We began having monthly meetings to discuss what could be done to accelerate longevity research (usually in oddball locations like salad bars or subterranean Japanese restaurants befitting our motley crew) and eventually hit upon the idea of crowdfunding. What drew us to this idea was that it was something tangible: a concrete way to move the needle on important research not only through funds, but through raised awareness. It is fine to talk and rabble-rouse about longevity, but we felt such efforts would be much more effective if they were paired with a clear and consistent call to action – a path to walk the walk, so to speak. As this idea coalesced we formed the nonprofit LEAF to support this initiative, and the rest is history. Not every one from the initial discussions in 2012 remained throughout the intervening years, but we are thankful to all who gave us ideas in those early days of the movement.

I’d like to hear your take on why we have to advocate and raise funds at all – why the whole world isn’t rising up in support of treatments for the causes of aging.

The reasons why people and society at large have not prioritized anti-aging research thus far are myriad: fear of radical change, a history of failed attempts making it seem like a fools errand, long timescales making it a difficult issue for election-focused politicians to support, etc. The reason I find most personally interesting relates to cognitive bias – specifically the fact that our built-in mental hardware is ill-equipped to handle questions like “do you want to live 100 more years?” If instead you ask the questions “Do you want to be alive tomorrow?” and “Given that your health and that of your loved ones remains the same, do you suspect your answer to the first question will change tomorrow?”, the answers tend to be more positive.

This leads me to conclude that the state of affairs is not necessarily as depressing for our cause as it might appear, and that reframing the issue of healthy life extension in a way that will inspire and unite the broader populace is possible. Aubrey de Grey has spoken about “Longevity Escape Velocity” in relation to the bootstrapping of biomedical research, but I think the same idea applies to the public perception of life extension as well. The sooner we can galvanize the public to support therapies that yield positive results the easier it will become to invite others to join in this great work. It is all about jump starting the positive feedback loop, and that is why we believe rallying the crowd behind critical research and trumpeting these successes publicly is so vitally important.

What the future plans for Lifespan.io and the Life Extension Advocacy Foundation?

In addition to scaling up our ability to run successful campaigns on Lifespan.io, we look forward to improving our infrastructure at LEAF by bringing on some staff members to join the team. LEAF has largely been a volunteer effort thus far, and having the support of a staff will allow us to take on more campaigns as well as further improve the workflow to create and promote them. This will also free me up personally to more actively pursue potential grand slams for the movement, such as collaborations with prominent YouTube science channels to engage the public and policy related goals like the inclusion of a more useful classification of aging in the ICD-11.

Do you have any favored areas in research at the moment? Is there any particular field for which you’d like to see researchers approaching you for collaboration?

Senolytics is certainly an exciting area of research right now (congratulations Major Mouse Testing Program!), and a combination of successful senolytics with stem cell therapies could be a potential game changer. That being said I’d also like to see projects which address the truly core mechanics of aging, such as how damage is aggregated during stem cell division, and the potential differences in this process between somatic and germ cells. How can the germ line renew itself for essentially infinity? The real mystery here is not that we grow old, but how we are born young.

A related question: where do you see aging and longevity research going over the next few years?

In the near future we will likely continue to see the pursuit of compounds which restore bodily systems failing with age to a more youthful state. This will include validating in higher organisms molecules that have shown this sort of promise: rapamycin, metformin, IL-33 for Alzheimer’s, etc. This approach may sound incremental, but it actually signals a great paradigm shift from the old system of mostly ineffective “preventative measures” such as antioxidants. Things like nicotinamide mononucleotide (NMN), IL-33 – if successful these types of therapies can be applied when you are old, and help restore your bodily systems to youthful levels. That would be a pretty big deal.

Funding is ever the battle in the sciences, and especially for aging. Obviously you have strong opinions on this topic. How can we change this situation for the better?

I believe the key to greater funding, both from public and private sources, is to build up an authentic and powerful grassroots movement in support of healthy life extension. Not only can such a movement raise funds directly, but it also communicates to businesses and governments that this is an issue worth supporting. An instructive example to look at here is the work of Mary Lasker and Sydney Farber to bring about the “War on Cancer”. Through galvanizing the public with efforts such as the “Jimmy Fund”, they effected social and political change on the issue, and helped turn cancer from a pariah disease into a national priority. If we all work together to build an inclusive and action-orientated movement, we can do the same.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries.
***
This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.

 

Major Mouse Testing Program Crowdfunding Campaign Announcement by International Longevity Alliance

Major Mouse Testing Program Crowdfunding Campaign Announcement by International Longevity Alliance

Comments 0 Comment
The New Renaissance HatInternational Longevity Alliance

******************************

Editor’s Note: The Rational Argumentator strongly supports the Major Mouse Testing Project crowdfunding campaign, and I have personally pledged $100 to this effort. Furthermore, I am honored that copies of my illustrated children’s book Death is Wrong are being made available as rewards for certain tiers of contributors to this research fundraiser.

~ Gennady Stolyarov II, Editor-in-Chief, The Rational Argumentator, May 11, 2016

The International Longevity Alliance is conducting a crowdfunding campaign to support the investigation of senolytic drugs’ potential to extend life. The team is going to study the combination of three senolytic drugs – Dasatinib, Venetoclax, and Quercetin – in mice, to see if the removal of senescent cells can ensure extended maximum lifespan. With highly devoted scientists and volunteers working for MMTP, the project needs only $60,000 to begin this experiment, as the researchers would need only to buy the mice and pay for their housing, the substances to test, and the battery of tests to analyze health changes.

Will you help to fund this research? Then please go to Lifespan.io, and choose the donation that suits you best and receive the deepest gratitude of the team and a nice useful souvenir to remember your input into the investigation of longevity therapies!

MMTP_Project1_StairFind out more about the International Longevity Alliance here.

Lifespan Challenge: Support the MitoSENS Mitochondrial Repair Project Research Fundraiser – Video by G. Stolyarov II

Lifespan Challenge: Support the MitoSENS Mitochondrial Repair Project Research Fundraiser – Video by G. Stolyarov II

Comments 0 Comment
The New Renaissance HatG. Stolyarov II
October 21, 2015
******************************

Mr. Stolyarov, author of “Death is Wrong” and Chief Executive of the Nevada Transhumanist Party (NTP), challenges all members of the NTP and the general public to donate to life-extension research – particularly, the ongoing MitoSENS Mitochondrial Repair Project for which crowdfunding is currently being conducted on Lifespan.io.

LifespanChallengeSign-513x396

Life Extension Advocacy Foundation Launches Lifespan.io – Press Release by Life Extension Advocacy Foundation

Life Extension Advocacy Foundation Launches Lifespan.io – Press Release by Life Extension Advocacy Foundation

Comments 0 Comment
The New Renaissance HatLife Extension Advocacy Foundation
August 28, 2015

******************************

Editor’s Note: Visit and contribute to Lifespan.io’s first crowdfunding research project, the SENS Research Foundation’s MitoSENS Mitochondrial Repair Project, here. I have personally donated $100 and encourage all supporters of life-extension research to assist this effort in reaching its $30,000 funding goal. ~ Gennady Stolyarov II, August 27, 2015

LEAF_1NEW YORK, Aug. 26, 2015 – The Life Extension Advocacy Foundation (LEAF) officially launches Lifespan.io, an online platform designed to bridge the gap between longevity researchers and the public who support breakthroughs happening in this burgeoning field.

Lifespan.io is a website designed to house today’s most promising life extension projects. People are invited to contribute financially to the ones they wish to support. This unique approach to crowdfunding gives the public the opportunity to learn about longevity research, meet the people making it happen, and allows them to be a part of promising, historical breakthroughs in life extension technologies.

Supported by biologists George Church and David Sinclair, who are members of LEAF’s Scientific Advisory Board, Lifespan.io is a collaborative environment that invites projects from a wide variety of sources.  Research organizations, nonprofit institutions, citizen scientists, as well as forprofit entities, may submit their projects. Submissions are evaluated and approved based on the legitimacy, the extent of the focus on extending healthy human lifespan, and the viability of the venture.

Organizations submitting launch projects include Harvard Medical School and the SENS Research Foundation.

LEAF President Keith Comito says, “By inviting the public to participate, the organization is creating an environment where everyone can be involved and have a stake in the results. Equitable distribution of the benefits that life extension technologies have to offer is the key to achieving the results we all want: healthier and longer lives. LEAF welcomes everyone to join us and discover more.”

LEAF also aims to educate and inform the public about longevity research and life-expanding advancements. Lifespan.io has a YouTube Channel, Facebook, and Twitter profile where people can find the latest in lifespan, aging, and longevity news. To participate in and lend support to current projects, visit www.Lifespan.io. Join the conversation with the #CrowdFundtheCure hashtag.

Those wishing to submit a project for funding consideration, or who want additional information about the various methods of promotional and scientific counseling offered by LEAF, are also invited to learn more on the website.

LEAF_2ABOUT LIFE EXTENSION ADVOCACY FOUNDATION

The Life Extension Advocacy Foundation is a nonprofit 501(C)(3) organization dedicated to promoting life extension, longevity, and aging research through crowdfunding and advocacy initiatives. Its mission is to connect the researchers and scientists developing the latest advancements with the people who support them through the Lifespan.io platform. Endorsed by top scientific leaders and experts from multiple disciplines, LEAF’s goal is to make all human life healthier and more vital, as well as longer. For more information, please visit www.Lifespan.io.

Photo – http://photos.prnewswire.com/prnh/20150825/260842

Media Contact: Desireé Duffy, Life Extension Advocacy Foundation, 6614789165, info@lifespan.io

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE: Life Extension Advocacy Foundation

Updates on a Crowdfunded Mouse Lifespan Study – Article by Reason

Updates on a Crowdfunded Mouse Lifespan Study – Article by Reason

Comments 0 Comment
The New Renaissance Hat
Reason
January 3, 2015
******************************

For all that I think it isn’t an efficient path forward, one likely to produce meaningful results in moving the needle on human life spans, there is considerable interest in testing combinations of existing drugs and various dietary compounds in mice to see if healthy life is extended. I expect that as public interest grows in the prospects for aging research to move from being an investigative to an interventional field, wherein researchers are actively trying to treat aging, we’ll only see more of this. There is certainly a sizable portion of the research community who think that the the best path ahead is in fact the pharmaceutical path of drug discovery in search of ways to slightly slow the aging process. To their eyes slightly slowing the aging process is all that is plausible, and adding five healthy years to life by 2035 would be a grand success. Google’s Calico initiative looks set to take that path, for example, which I is why I’m not all that hopeful it will produce meaningful results in terms of healthy years gained and ways to help the old suffer less.

There is a considerable overlap between researchers aiming to gently slow aging via drug discovery and researchers whose primary motivation is still investigation, not intervention: to produce a complete catalog of metabolism and how it changes with age, and it’s someone else’s problem to actually use that data. So we have, for example, the Interventions Testing Program at the NIA. This program was long fought for by researchers tired of the lack of rigor in most mouse life span studies, and the people involved are essentially engaged in replacing a lot of carelessly optimistic past results with the realistic view that very little other than calorie restriction and exercise actually does reliably extend life in mice if you go about the studies carefully. This is good science, but it isn’t the road to extended human life spans: it instead has much more to do with understanding the process of aging at a very detailed level. That task is vast and will take a very long time even in this age of computing and biotechnology.

To my eyes the right way to go is the repair approach: build the biotechnologies needed to repair the forms of cellular and molecular damage produced as a side-effect of the normal operation of metabolism, and which clearly distinguish old tissues from young tissues. If you want rejuvenation of the old, a path to adding decades to healthy life, and to eliminate all age-related disease, then repair is the way to go. Fix the damage, don’t just tinker with the engines of life in ways that might possibly slow down damage accumulation just a little. This strategic direction can allow researchers to largely bypass the great complexity of the progression of aging and focus instead on fixing things that are already well known and well cataloged. But I say this a lot, and will continue to do so until more than just a small fraction of the research community agree with me.

Back to mice and lifespan studies: in this day and age institutional research is far from the only way to get things done. Early-stage research is becoming quite cheap as the tools of biotechnology improve, and the global economy allows quality scientific work to be performed in locations that are lot less expensive than the US or Western Europe. We have crowdfunding, the internet, and a supportive community, which means that any group of ambitious researchers can raise a few tens of thousands of dollars and set an established lab in the Ukraine to running a set of mouse lifespan studies. So that happened back in 2013, and has been ongoing since then despite the present geopolitical issues in that part of the world. It is perhaps worth noting that this is the same group that found no effect on longevity from transfusions of young blood plasma into old mice. The studies mentioned below used pre-aged mice, starting at old age as a way to try to discover effects more rapidly, an approach that is fairly widespread.

I am a little mouse and I want to live longer: updates

Quote:

Dear contributors, we wish you a happy New Year! We are sorry to be taken by a very-expected but very time-consuming c60 lifespan study to digest the data in a way to make the long report we had announced. So, for the New Year and in order for you not to wait longer, please find at least the main results so far:

1) 23 months old C57BL6 mice received a mixture of 6 therapies that had already been reported to extend the lifespan of mice: Aspirin; Everolimus (mTOR inhibitor, similar action as rapamycin); Metoprolol (beta blocker); Metformin (anti-diabetic drug); Simvastatin (lowers LDL cholesterol); Ramipril (ACE inhibitor).

The drugs were given in the food, at doses that had been reported to extend lifespan … when taken individually. Some people are given that combination of medicines so we hoped that the drug interaction would not be too damaging, and we had wondered if some lifespan synergy within some of these drugs could lead to an overall high lifespan (e.g. if the different drugs improve different functions). But we observed a lifespan reduction in males and in females.

2) In the food of some remaining females we mixed low doses of 4 medications against cardiovascular conditions: Simvastatin; Thiazide (lowers blood pressure); Losartan potassium (angiotensin receptor blocker, lowers blood pressure); Amlodipine (calcium channel blocker, lowers blood pressure).

The question was: taken at a low-to-medium dose, could these drugs that many aged persons take have some overall preventive effect? We transposed to mice an ongoing polypill clinical trial in the UK, using a basic human-mouse conversion scale. Again, a decrease in lifespan was observed.

3) Adaptations of the first combination of drugs actually extended lifespan!

We started at age 18 months instead of 23 months, reduced the dose (as a function of weight) and gave a) the 6 compounds b) ‘only’ aspirin+metformin+everolimus. The results are to be analysed in greater details as we haven’t analyzed the latest data yet. Also, whatever the refined analysis, we would already like to indicate that it would be good to reproduce the experiment in some other conditions, e.g. hybrid mice; in particular as the mortality rates of these mice was higher than the first series (but in a consistent way that supports the life extending effect).

4) Ongoing C60 experiments

After many difficulties in setting the experiment (cross-border transportation in current geopolitical times, checking absorption in mice/ detecting C60/correct source of C60, administration tried in food and replaced by gavage, training for gavage and various measures) we have transposed the popular lifespan test with c60 fullerenes reported in rats by Baati et al. to mice (CBA strain, common in the lab) and with more animals (N=17 per group). There are three groups (gavage of water, of olive oil, of C60 dissolved in olive oil), there are … a lot of health measures and a lot of gavage (at the beginnings of the experiment as administrations are first very frequent and then gradually less frequent). Given that the experiment starts with mid-aged animals, the results are expected for the beginning of 2016.

The original C60 results from a few years back were greeted with some skepticism in the research community, given the very large size of the effect claimed and the small number of animals tested. There was, I think, also a certain annoyance: now that someone had made what was on the face of it an unlikely claim of significant lifespan extension via administration of C60, then some other group was going to have to waste their time in disproving it. We’ll see how that all turns out, I suppose. This is science as it works in practice.

At some point the broad structural classes of research illustrated by the Interventions Testing Program and this crowdfunded mouse study will meet in the middle, and the process of funding and organizing scientific programs will be a far more complicated, dynamic, and public affair than is presently the case. I think this will be for the better. All that we have we owe to science, and a majority of the public thinks all too little of the work that will determine whether they live in good health or suffer and die a few decades from now. The more they can see what is going on, the better for all of us in the end, I think.

Reason is the founder of The Longevity Meme (now Fight Aging!). He saw the need for The Longevity Meme in late 2000, after spending a number of years searching for the most useful contribution he could make to the future of healthy life extension. When not advancing the Longevity Meme or Fight Aging!, Reason works as a technologist in a variety of industries. 
***

This work is reproduced here in accord with a Creative Commons Attribution license. It was originally published on FightAging.org.

Life-Extension Activism Opportunities for All – Article by G. Stolyarov II

Life-Extension Activism Opportunities for All – Article by G. Stolyarov II

Comments 0 Comment
The New Renaissance Hat
G. Stolyarov II
June 5, 2014
******************************

You do not need to be a biologist or medical doctor to help hasten the arrival of indefinite life extension. An important array of activist endeavors, which are laying the groundwork for the eventual achievement of unlimited lifespans, can be implemented by anybody. They range from giving out books to playing games to simply running one’s computer – all the while making important contributions to scientific progress and the receptiveness of the general culture to the feasibility and desirability of indefinite longevity.

If you want to glimpse the possibilities in 90 seconds, watch my recent video, “What Anyone Can Do to Advance Indefinite Life Extension”.

In this article, I offer a more detailed overview of some immediately available activism options that anyone can pursue. The time commitment involved in each ranges from minimal to modest, but virtually any of them can fit into the schedule of anyone who recognizes the value of this amazing life we have and the importance of prolonging it as far as possible.

Movement for Indefinite Life Extension (MILE)

MILE_Logo
The Movement for Indefinite Life Extension (MILE) is not a formal organization, but rather a coalition of activists working toward the common goal of achieving indefinite lifespans for people alive today. The MILE coordinates projects and shares articles, images, and news stories via its Facebook group – also accessible using the URL http://themile.info. One of the MILE’s major purposes is to raise awareness of the feasibility and desirability of indefinite life extension and to create a critical mass of support for this most vital of goals. The number of “likes” on the MILE Facebook page is a concise indicator of the movement’s reach, and the eventual goal of the MILE is to achieve 8 million likes by July 17, 2017. Following an incremental approach, the MILE seeks to raise its support by an order of magnitude each year. The goal of 800 supporters was readily exceeded prior to July 17, 2013, and the MILE has launched a concerted effort to reach its Year 2 goal of 8,000 supporters by July 17, 2014. Eric Schulke, who spearheads and coordinates the efforts of the MILE, has launched the MILE Year 2 Goal Fundraiser to fund hundreds of dollars of Facebook advertisements that have already shown success in spreading the message of indefinite life extension to new demographics.

I am proud to have contributed resources to run several ads for MILE that incorporate the core message and the cover image of my children’s book Death is Wrong. These MILE/Death is Wrong ads were designed by my wife and illustrator Wendy Stolyarov and are accompanied by the following text:

Death is WRONG.
Together we can fight it.
Join the Movement for Indefinite Life Extension.

Reaper_MILE_Ad_FBDIW_MILE_AdTo help the MILE reach its Year 2 goal, you can start by clicking the “Like” button on the MILE Facebook page. Beyond that, if you would like to contribute to the advertising campaign and even develop your own custom advertisement that conveys the message of indefinite life extension, this would go a long way toward building the critical mass needed to catalyze public support for life-extension research.

Death is Wrong Book Distribution to Children

DIW_HannaAfter the successful conclusion on April 23, 2014, of my Indiegogo fundraiser to spread over 1,000 copies of the illustrated children’s book Death is Wrong to kids, free of cost to them, I have worked assiduously to coordinate a worldwide distribution effort. Already, 644 out of the 1,029 total available books have been sent to longevity activists throughout the world. Countries where the books have been shipped thus far include the United States, Canada, Mexico, the United Kingdom, the Netherlands, Poland, India, Indonesia, and Singapore. Tens of dedicated longevity supporters have already come forward to request absolutely free shipments of books, but we need more activists to help us distribute the remaining 385 books in their local areas.

Recipients have wide discretion to use their creativity in how to offer the Death is Wrong books to children, as long as the books are made available free of cost and are not resold. Books may be given away to kids directly, lent to multiple kids, given to schools and libraries that will accept them, or used at public readings – among possible other options.

The early successes of the book-distribution effort are among the most heartening and encouraging developments I have observed. Here are some photographs that longevity activists have sent in of their book shipments.

DIW_Amechazurra_ShipmentDIW_Books_Received_CvdB_3
DIW_Books_Received

Here is a charming interview by Aleksander Kelley of his sister Hanna, who is spreading Death is Wrong to the kids she knows.

Help make future scenes like this happen. Requesting a shipment of Death is Wrong books is simple. Send me an e-mail to gennadystolyarovii@gmail.com with (i) your name, (ii) your mailing address, (iii) your statement of support for indefinite life extension, (iv) the number of copies of Death is Wrong requested, and (v) your plan for spreading the books to children, free of cost to them.

Once the shipments arrive, any additional images and videos of the books and events at which they are shared would be most welcome. They can help spread the message of indefinite life extension even further and show the world that the momentum for this cause continues to grow.

Distributed Computing for Medical Science

Would you like to help cure cancer, Alzheimer’s disease, Huntington’s disease, and other deadly ailments, just by running your computer? Most people’s computers spend much time absolutely idle; how about putting that idle time to good use, at minimal additional cost? Distributed computing initiatives such as Folding@home, Rosetta@home, and World Community Grid are absolutely free to join. You just need to download a program that runs the calculations involved in protein-folding simulations and other research efforts while you are not using your computer. Already, these distributed computing initiatives have led to several major medical research breakthroughs, such as this one by Chiba Cancer Center in Japan, which has identified seven drug candidates in the fight against childhood cancer. You can read more about the applications of protein-folding simulations to disease research in this brief post by David Baker of the University of Washington.

While no single medical breakthrough will achieve indefinite lifespans yet, every victory against death and diseases will help us approach that goal. The more of us survive the common killers of our time, the more of us stand a chance of personally witnessing the arrival of longevity escape velocity.

As an additional way to raise the profile of the ideas of indefinite life extension, it is recommended to join a distributed-computing team that explicitly embraces the struggle against senescence and death. On Folding@home, The Longevity Meme team has been folding for years and is ranked 156th out of 220,186 teams as of June 5, 2014. I am spearheading a collaborative effort between The Longevity Meme team, LongeCity, and my online magzine – The Rational Argumentator – to attract renewed participation in Folding@home and The Longevity Meme team among longevity advocates. To provide an additional incentive to join, I am offering a series of five Protein Folding for Life Extension Open Badges, designed by Wendy Stolyarov and available via Badg.us.

FaH-Square-L1 FaH-Square-L2 FaH-Square-L3 FaH-Square-L4 FaH-Square-L5These are badges that you can store and share via Mozilla Backpack to share your achievements with others. The following are the qualifying criteria for each badge:

● Level 1: 5,000 points earned on Folding@home;

● Level 2: 10,000 points earned on Folding@home;

● Level 3: 50,000 points earned on Folding@home;

● Level 4: 100,000 points earned on Folding@home;

● Level 5: 500,000 points earned on Folding@home.

To request a badge, simply send an e-mail to gennadystolyarovii@gmail.com. Include your user name on Folding@home so that your points earned could be verified. You can earn a badge no matter what team you are on, if any, as everyone’s commitment of resources to the protein-folding effort helps the prospects of indefinite life extension. However, you are also encouraged to join The Longevity Meme team in order to help improve its ranking and raise public awareness of the effort life-extension activists are putting into the fight against disease.

On Rosetta@home, the LongeCity team explicitly embraces the ideas of indefinite life extension. On World Community Grid, the Endthedisease team supports life extension and has been involved in numerous disease-fighting computational efforts since 2007. Later this year, the Endthedisease team is anticipated to begin running contests with prizes for top contributors.

Games to Fight Disease

By flying a spaceship through an asteroid field in a computer game, you can help cancer researchers analyze data at a much faster rate than they could before. Play to Cure: Genes in Space is a mobile game released by Cancer Research UK, which anyone with a tablet or mobile phone can play for free. The stated aim of this game is to hasten the day when all cancers are cured – which is, incidentally, the key objective of one of the seven prongs of Dr. Aubrey de Grey’s SENS approach; Dr. de Grey has emphasized that cancer is by far the predominant way by which age-related nuclear mutations harm us.

You can read about the mechanics of and science behind Play to Cure here and watch this video introduction to the game.

Foldit is another free game that enthusiasts of life-extension research can play in order to add the human touch to protein-folding simulations. In 2011, Foldit players discovered the protein structure of a retroviral protease of the Mason-Pfizer monkey virus, an AIDS-like disease in monkeys.

See this list from the Citizen Science Center for more possibilities regarding games you could play and simultaneously participate in innovative citizen-science initiatives – including many devoted to the fight against disease. Games hold out the promise of enabling monumental contributions to scientific research by the general public. A game designed to be sufficiently engaging could attract thousands of non-scientists to do the work that research scientists could conceivably outsource in order to accelerate the rate at which certain kinds of data analysis are performed. The more quickly scientists can iterate through their experiments as a result, the sooner the cures to major diseases will arrive.

Conclusion

Of course, I would urge all life-extension supporters to donate even modest amounts of money to research and advocacy organizations such as the SENS Research Foundation and the Methuselah Foundation, as well as crowdfunded life-extension research projects that are being undertaken with increasing frequency. Yet, I hope that this overview has led readers to recognize that much can be done in addition to monetary donations. Integrate the active pursuit of indefinite longevity into your life, and you will continue to find easy but extremely important ways to become part of the solution to the most pressing problem of all time. Through our efforts, we will hopefully someday be able to celebrate humankind’s greatest victories in the fight against our mutual enemy: death.

What Anyone Can Do to Advance Indefinite Life Extension – Video by G. Stolyarov II

What Anyone Can Do to Advance Indefinite Life Extension – Video by G. Stolyarov II

Comments 0 Comment

Mr. Stolyarov provides a quick overview of ideas that anyone can implement to accelerate the pace of technological progress and bring about indefinite life extension for many who are alive today.

This is Mr. Stolyarov’s entry in the MILE Video Contest.

References
– SENS Research Foundation
– Methuselah Foundation
– MILE – Movement for Indefinite Life Extension
– Folding@home
– The Longevity Meme Folding@home Team
– Open Badges for Participating in Folding@home
– Rosetta@home
– World Community Grid
– Foldit
– Play to Cure

Support the “Little Mouse” Crowdfunded Life-Extension Research Project! – Post by G. Stolyarov II

Support the “Little Mouse” Crowdfunded Life-Extension Research Project! – Post by G. Stolyarov II

Comments 0 Comment
The New Renaissance Hat
G. Stolyarov II
October 4, 2013
******************************

As part of my escalating efforts to advance the prospects of radical life extension through my individual actions, I have donated $50 to an ambitious new crowdfunding project to research longevity-enhancing treatments in mice.

This international project, undertaken by researchers at the Kiev Institute of Gerontology and supported by the Methuselah Foundation and the SENS Research Foundation, has an Indiegogo fundraising page, titled “I am a little mouse and I want to live longer!”, where contributions can be made.

I am proud to donate to this effort to support longevity research through crowdfunding. This project allows those of us who seek longer lifespans, and who wish to advance the science that will get us there, to contribute directly in a manner whereby each of us can make a sizable fraction of the difference for this research effort. I look forward to the great work that this project will accomplish. Achieving statistically significant mouse life extension in the near future could trigger massive public interest and the influx of major research funds to attain increasingly ambitious life-extension goals in higher-order mammals, culminating in us.

The project has already raised $8,673 and has 16 days remaining to reach its $15,000 goal. The Methuselah Foundation will match each $1,000 given with an equivalent donation – so it is possible to double one’s impact by contributing funds to this research effort.